2017
DOI: 10.1016/j.jagp.2017.01.129
|View full text |Cite
|
Sign up to set email alerts
|

Medical and Psychiatric Comorbidities Associated with Opiate Use Disorder in the Geriatric Population: A Systematic Review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2018
2018

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Opioid use disorders, which in 2015 were estimated to have affected nearly 16 million people worldwide (Schuckit, 2016), contribute to risk of overdose death, promote risky behaviors, and complicate treatment for HIV and other co-morbid conditions (Becker et al, 2008;Broz and Ouellet, 2008;Estrada, 2005;Johnson et al, 2013;Kester et al, 2017). While much of the increasing trend in opioid use disorders over the past decade has been driven by rising rates of prescription opioid misuse, as of 2016, heroin use still accounted for about 76% of new opioidrelated treatment admissions in the United States (SAMSHA 2018) 1 and, as of 2015, for about 80% of new opioid-related treatment demands in Europe (European Monitoring Centre for Drugs and Drug Addiction, 2017).…”
Section: Introductionmentioning
confidence: 99%
“…Opioid use disorders, which in 2015 were estimated to have affected nearly 16 million people worldwide (Schuckit, 2016), contribute to risk of overdose death, promote risky behaviors, and complicate treatment for HIV and other co-morbid conditions (Becker et al, 2008;Broz and Ouellet, 2008;Estrada, 2005;Johnson et al, 2013;Kester et al, 2017). While much of the increasing trend in opioid use disorders over the past decade has been driven by rising rates of prescription opioid misuse, as of 2016, heroin use still accounted for about 76% of new opioidrelated treatment admissions in the United States (SAMSHA 2018) 1 and, as of 2015, for about 80% of new opioid-related treatment demands in Europe (European Monitoring Centre for Drugs and Drug Addiction, 2017).…”
Section: Introductionmentioning
confidence: 99%